These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Ocular manifestation in treated multibacillary Hansen's disease. Parikh R; Thomas S; Muliyil J; Parikh S; Thomas R Ophthalmology; 2009 Nov; 116(11):2051-7.e1. PubMed ID: 19766316 [TBL] [Abstract][Full Text] [Related]
23. Recent advances in the treatment of leprosy. Ishii N Dermatol Online J; 2003 Mar; 9(2):5. PubMed ID: 12639458 [TBL] [Abstract][Full Text] [Related]
24. Hansen's disease: the need for increased healthcare provider awareness and re-training. Ojinmah UR; Onyekonwu CL; Ozoh GA; Onyekonwu GC Niger J Med; 2012; 21(4):427-31. PubMed ID: 23304951 [TBL] [Abstract][Full Text] [Related]
25. [Some immunological aspects in the reaccional states of Hansen disease]. Rada E; Nacarid A; Convit J Invest Clin; 2005 Dec; 46(4):381-9. PubMed ID: 16353545 [TBL] [Abstract][Full Text] [Related]
26. Hansen's disease (leprosy). Wariyar B Nebr Med J; 1996 May; 81(5):147-8. PubMed ID: 8975147 [No Abstract] [Full Text] [Related]
27. Leprosy in the Heartland. Keegan A; Gubbrud J; Hockhausen K; Peck H S D Med; 2023 Nov; 76(11):486-493. PubMed ID: 38985957 [TBL] [Abstract][Full Text] [Related]
28. [Prevalence of Hansen's disease cases in Indonesia after the introduction of multi-drug therapy]. Fukunishi S Nihon Hansenbyo Gakkai Zasshi; 2001 Aug; 70(3):157-61. PubMed ID: 11712507 [No Abstract] [Full Text] [Related]
29. Leprosy (Hansen's disease) in South Dakota. Burrish G; Hartmann A; Lockwood W S D J Med; 1996 Jun; 49(6):185-7. PubMed ID: 8693339 [TBL] [Abstract][Full Text] [Related]
30. [Development of antituberculous drugs: current status and future prospects]. Tomioka H; Namba K Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [TBL] [Abstract][Full Text] [Related]
31. Relapse in Hansen's disease. Kunz K Hawaii Med J; 1988 Feb; 47(2):70-5. PubMed ID: 3284841 [No Abstract] [Full Text] [Related]
32. A case of leprosy in a nonendemic country. Asperges E; Bagnarino J; Ancarani C; Baggini G; Filardo M; Monzillo V; Barbarini D; Bruno R; Paulli M; Baldanti F Int J Infect Dis; 2024 Jun; 143():107004. PubMed ID: 38479578 [No Abstract] [Full Text] [Related]
33. Analysis of socioeconomic condition and bacillary index with respect to the development of Hansen's disease. Gautam S; Sharma D; Singh S; Arora M; Goel A; Bisht D Int J Mycobacteriol; 2023; 12(3):254-260. PubMed ID: 37721229 [TBL] [Abstract][Full Text] [Related]
34. Hansen's Disease and Rheumatoid Arthritis Crossover of Clinical Symptoms: A Case Series of 18 Patients in the United States. Labuda SM; Schieffelin JS; Shaffer JG; Stryjewska BM Am J Trop Med Hyg; 2017 Dec; 97(6):1726-1730. PubMed ID: 29141716 [TBL] [Abstract][Full Text] [Related]
35. Iatrogenic stigma in outpatient treatment for Hansen's disease (leprosy) in Brazil. White C Health Educ Res; 2008 Feb; 23(1):25-39. PubMed ID: 17229777 [TBL] [Abstract][Full Text] [Related]
36. The diagnostic challenge of Hansen's disease. Chambers JA; Baffi CW; Nash KT Mil Med; 2009 Jun; 174(6):652-6. PubMed ID: 19585783 [TBL] [Abstract][Full Text] [Related]
37. Hansen's disease in native-born citizens of the United States. Joseph BZ; Yoder LJ; Jacobson RR Public Health Rep; 1985; 100(6):666-71. PubMed ID: 3934705 [TBL] [Abstract][Full Text] [Related]
38. The clinical and immunological features of leprosy. Walker SL; Lockwood DN Br Med Bull; 2006; 77-78():103-21. PubMed ID: 17090777 [TBL] [Abstract][Full Text] [Related]
39. The impact of leprosy control on the transmission of M. leprae: is elimination being attained? Richardus JH; Habbema JD Lepr Rev; 2007 Dec; 78(4):330-7. PubMed ID: 18309706 [TBL] [Abstract][Full Text] [Related]
40. Reversal reaction to Hansen's disease. Jih MH; Kimyai-Asadi A; Levis WR J Drugs Dermatol; 2002 Jul; 1(1):70-1. PubMed ID: 12847760 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]